Skip to Content

SZ 327 (Mycophenolate mofetil 500 mg)

Pill with imprint SZ 327 is Purple, Capsule-shape and has been identified as Mycophenolate mofetil 500 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; bullous pemphigoid; organ transplant, rejection prophylaxis; cogan's syndrome; graft-versus-host disease (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for SZ 327

Mycophenolate mofetil

SZ 327
500 mg
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
croscarmellose sodium
hydroxypropyl cellulose
ferrosoferric oxide
ferric oxide red
magnesium stearate
microcrystalline cellulose
polyethylene glycol
magnesium silicate
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0801 Amerisource Health Services

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.